(Q44313218)

English

Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Robert R. Recker

2

object named as

R R Recker

0 references

object named as

R Müller

4

0 references

author name string

S Y Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

R R Recker

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

M Hannan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

F Bauss

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

45-55

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Esophagitis associated with the use of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates: preclinical aspects and use in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mass in female cynomolgus macaques: a cross-sectional and longitudinal study by age.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased bone mass and strength in ovariectomized cynomolgus monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate: an unrecognized problem in gastrointestinal tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term effect of ovariectomy on the quality and quantity of cortical bone in the young cynomolgus monkey: a comparison of density fractionation and histomorphometric techniques

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevention and treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of osteoporosis with bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900923-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S8756-3282(02)00923-7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44313218&oldid=2109368300"